142 related articles for article (PubMed ID: 25000235)
1. Patch test results in psoriasis patients on biologics.
Kim N; Notik S; Gottlieb AB; Scheinman PL
Dermatitis; 2014; 25(4):182-90. PubMed ID: 25000235
[TBL] [Abstract][Full Text] [Related]
2. Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis.
Tan E; Baker C; Foley P
Australas J Dermatol; 2013 Nov; 54(4):259-63. PubMed ID: 24164178
[TBL] [Abstract][Full Text] [Related]
3. Biological treatments for moderate-to-severe psoriasis: indirect comparison.
Galván-Banqueri M; Marín Gil R; Santos Ramos B; Bautista Paloma FJ
J Clin Pharm Ther; 2013 Apr; 38(2):121-30. PubMed ID: 23442134
[TBL] [Abstract][Full Text] [Related]
4. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
Carretero G; Ferrandiz C; Dauden E; Vanaclocha Sebastián F; Gómez-García FJ; Herrera-Ceballos E; De la Cueva-Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina-Gibert M; López-Estebaranz JL; Ferrán M; Torrado R; Carrascosa JM; Carazo C; Rivera R; Jiménez-Puya R; García-Doval I;
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):156-63. PubMed ID: 24684267
[TBL] [Abstract][Full Text] [Related]
5. Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab.
van Lümig PP; Driessen RJ; Roelofs-Thijssen MA; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2011 Aug; 165(2):375-82. PubMed ID: 21428975
[TBL] [Abstract][Full Text] [Related]
6. Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.
Al-Mutairi N; Nour T; Al-Rqobah D
Expert Opin Biol Ther; 2013 May; 13(5):625-9. PubMed ID: 23527597
[TBL] [Abstract][Full Text] [Related]
7. Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).
Wentworth AB; Yiannias JA; Keeling JH; Hall MR; Camilleri MJ; Drage LA; Torgerson RR; Fett DD; Prakash AV; Scalf LA; Allen EM; Johnson JS; Singh N; Nordberg Linehan DL; Killian JM; Davis MD
J Am Acad Dermatol; 2014 Feb; 70(2):269-75.e4. PubMed ID: 24268786
[TBL] [Abstract][Full Text] [Related]
8. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
9. Use of the North American Contact Dermatitis Group Standard 65-allergen series alone in the evaluation of allergic contact dermatitis: a series of 794 patients.
Cohen DE; Rao S; Brancaccio RR
Dermatitis; 2008; 19(3):137-41. PubMed ID: 18627685
[TBL] [Abstract][Full Text] [Related]
10. [Adverse events during biological therapy -- focusing on dermatological side-effects].
Nagy G; Lukács K; Sziray A; Fazekas K; Florián A; Tamási L; Károlyi Z
Orv Hetil; 2011 Feb; 152(6):212-20. PubMed ID: 21278026
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
Rheumatology (Oxford); 2015 Jul; 54(7):1170-6. PubMed ID: 25504896
[TBL] [Abstract][Full Text] [Related]
12. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
[No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006.
Hogeling M; Pratt M
Dermatitis; 2008; 19(2):86-9. PubMed ID: 18413109
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.
Gniadecki R; Bang B; Bryld LE; Iversen L; Lasthein S; Skov L
Br J Dermatol; 2015 Jan; 172(1):244-52. PubMed ID: 25132294
[TBL] [Abstract][Full Text] [Related]
16. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D
Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397
[TBL] [Abstract][Full Text] [Related]
17. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
Famenini S; Wu JJ
J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
[TBL] [Abstract][Full Text] [Related]
18. Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.
Menting SP; Sitaram AS; Bonnerjee-van der Stok HM; de Rie MA; Hooft L; Spuls PI
Br J Dermatol; 2014 Oct; 171(4):875-83. PubMed ID: 24673245
[TBL] [Abstract][Full Text] [Related]
19. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004.
Zug KA; Rietschel RL; Warshaw EM; Belsito DV; Taylor JS; Maibach HI; Mathias CG; Fowler JF; Marks JG; DeLeo VA; Pratt MD; Sasseville D; Storrs FJ
J Am Acad Dermatol; 2008 Sep; 59(3):426-31. PubMed ID: 18597890
[TBL] [Abstract][Full Text] [Related]
20. Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients.
Hoffmann JH; Knoop C; Enk AH; Hadaschik EN
J Dermatol Sci; 2014 Dec; 76(3):180-5. PubMed ID: 25306295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
